Free Trial
NASDAQ:AMED

Amedisys (AMED) Stock Price, News & Analysis

Amedisys logo
$91.89 -1.10 (-1.18%)
Closing price 04:00 PM Eastern
Extended Trading
$91.90 +0.01 (+0.01%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Amedisys Stock (NASDAQ:AMED)

Key Stats

Today's Range
$91.69
$92.99
50-Day Range
$90.43
$92.99
52-Week Range
$82.15
$98.95
Volume
489,159 shs
Average Volume
397,554 shs
Market Capitalization
$3.01 billion
P/E Ratio
36.46
Dividend Yield
N/A
Price Target
$101.00
Consensus Rating
Hold

Company Overview

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Remove Ads

Amedisys Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

AMED MarketRank™: 

Amedisys scored higher than 65% of companies evaluated by MarketBeat, and ranked 342nd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Amedisys has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Amedisys has only been the subject of 1 research reports in the past 90 days.

  • Read more about Amedisys' stock forecast and price target.
  • Earnings Growth

    Earnings for Amedisys are expected to grow by 10.00% in the coming year, from $4.40 to $4.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Amedisys is 36.46, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.03.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Amedisys is 36.46, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.18.

  • Price to Earnings Growth Ratio

    Amedisys has a PEG Ratio of 1.78. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Amedisys has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Amedisys' valuation and earnings.
  • Percentage of Shares Shorted

    8.32% of the float of Amedisys has been sold short.
  • Short Interest Ratio / Days to Cover

    Amedisys has a short interest ratio ("days to cover") of 6.7.
  • Change versus previous month

    Short interest in Amedisys has recently decreased by 7.96%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Amedisys does not currently pay a dividend.

  • Dividend Growth

    Amedisys does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.32% of the float of Amedisys has been sold short.
  • Short Interest Ratio / Days to Cover

    Amedisys has a short interest ratio ("days to cover") of 6.7.
  • Change versus previous month

    Short interest in Amedisys has recently decreased by 7.96%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Amedisys has a news sentiment score of 1.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Amedisys this week, compared to 4 articles on an average week.
  • Search Interest

    1 people have searched for AMED on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Amedisys to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Amedisys insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.10% of the stock of Amedisys is held by insiders.

  • Percentage Held by Institutions

    94.36% of the stock of Amedisys is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Amedisys' insider trading history.
Receive AMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amedisys and its competitors with MarketBeat's FREE daily newsletter.

AMED Stock News Headlines

Oppenheimer moving to Perform from Not Rated on Amedisys
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
William Blair Reaffirms Their Hold Rating on Amedisys (AMED)
See More Headlines

AMED Stock Analysis - Frequently Asked Questions

Amedisys' stock was trading at $90.79 on January 1st, 2025. Since then, AMED shares have increased by 1.2% and is now trading at $91.89.
View the best growth stocks for 2025 here
.

Amedisys, Inc. (NASDAQ:AMED) posted its quarterly earnings results on Wednesday, February, 26th. The health services provider reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.05 by $0.09. The health services provider earned $598.05 million during the quarter, compared to analysts' expectations of $602.38 million. Amedisys had a net margin of 3.57% and a trailing twelve-month return on equity of 12.20%.

Top institutional shareholders of Amedisys include Versant Capital Management Inc (0.01%) and MassMutual Private Wealth & Trust FSB. Insiders that own company stock include Denise M Bohnert and Michael Paul North.
View institutional ownership trends
.

Shares of AMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amedisys investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
2/26/2025
Today
4/04/2025
Next Earnings (Estimated)
4/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Home health care services
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:AMED
Employees
20,000
Year Founded
1982

Price Target and Rating

Average Stock Price Target
$101.00
High Stock Price Target
$101.00
Low Stock Price Target
$101.00
Potential Upside/Downside
+10.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
36.42
Forward P/E Ratio
20.86
P/E Growth
1.78
Net Income
$-9,750,000.00
Pretax Margin
5.80%

Debt

Sales & Book Value

Annual Sales
$2.35 billion
Cash Flow
$6.20 per share
Price / Cash Flow
14.80
Book Value
$34.31 per share
Price / Book
2.67

Miscellaneous

Free Float
32,066,000
Market Cap
$3.01 billion
Optionable
Optionable
Beta
0.76

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:AMED) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners